Article Details
Retrieved on: 2023-01-08 18:28:46
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Morgan Stanley analysts adjusted the rating while noting that they expect Moderna's first interim analysis from its Ph3 RSV vaccine study in the ...
Article found on: pulse2.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here